Does TAVI reduce mortality or adverse events compared to SAVR in patients with aortic valve stenosis?
The choice between TAVI and SAVR should be individualized due to similar mortality but differing adverse event profiles.
Given similar mortality risks but different patterns of adverse events, the choice between TAVI and SAVR remains an individual one.
Wagner et al. (Tue,) studied this question.